Dosing of Aminoglycosides To Rapidly Attain Pharmacodynamic Goals and Hasten Therapeutic Response by Using Individualized Pharmacokinetic Monitoring of Patients with Pneumonia Caused by Gram-Negative Organisms

Benzer Materyaller

• Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria
  Yazar:: Kashuba, Angela D. M., ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• Comparative Pharmacokinetics and Pharmacodynamic Target Attainment of Ertapenem in Normal-Weight, Obese, and Extremely Obese Adults
  Yazar:: Chen, M., ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Simplified Estimation of Aminoglycoside Pharmacokinetics in Underweight and Obese Adult Patients
  Yazar:: Pai, Manjunath P., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing.
  Yazar:: Demczar, D J, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target
  Yazar:: Martinez, Marilyn N., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)